Theratechnologies Historical Income Statement

THTX Stock

USD 1.20 0.01 0.83%

Historical analysis of Theratechnologies income statement accounts such as Research Development of 36.7 M, Cost Of Revenue of 23.7 M, Total Operating Expenses of 87.9 M or Income Tax Expense of 508.4 K can show how well Theratechnologies performed in making a profits. Evaluating Theratechnologies income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Theratechnologies's future profits or losses.

Cash Flow Balance Sheet Income Statement

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Theratechnologies latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Theratechnologies is a good buy for the upcoming year.

Net Income Gross Profit

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Theratechnologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

For more information on how to buy Theratechnologies Stock please use our How to Invest in Theratechnologies guide.

About Theratechnologies Income Statement Analysis

Theratechnologies Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Theratechnologies shareholders. The income statement also shows Theratechnologies investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Theratechnologies Income Statement Chart

At this time, Theratechnologies' Total Revenue is fairly stable compared to the past year. Gross Profit is likely to rise to about 75 M in 2024, whereas Depreciation And Amortization is likely to drop slightly above 3.1 M in 2024.

Depreciation And Amortization Total Revenue Other Operating Expenses Research Development Cost Of Revenue

Depreciation And Amortization

The systematic reduction in the recorded value of an intangible asset. This includes the allocation of the cost of tangible assets to periods in which the assets are used, representing the expense related to the wear and tear, deterioration, or obsolescence of physical assets and intangible assets over their useful lives.

Total Revenue

Total revenue comprises all receipts Theratechnologies generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Theratechnologies. It is also known as Theratechnologies overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Cost Of Revenue

Cost of Revenue is found on Theratechnologies income statement and represents the costs associated with goods and services Theratechnologies provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.

Most accounts from Theratechnologies' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Theratechnologies current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Theratechnologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

For more information on how to buy Theratechnologies Stock please use our How to Invest in Theratechnologies guide.At this time, Theratechnologies' Total Revenue is fairly stable compared to the past year. Gross Profit is likely to rise to about 75 M in 2024, whereas Depreciation And Amortization is likely to drop slightly above 3.1 M in 2024.

	2021	2022	2023	2024 (projected)
Total Revenue	80.1M	81.8M	94.0M	98.7M
Depreciation And Amortization	12.0M	3.3M	3.8M	3.1M

Total Revenue Depreciation And Amortization

Theratechnologies income statement Correlations

	Depreciation And Amortization	Total Revenue	Gross Profit	Other Operating Expenses	Operating Income	Ebit	Research Development	Ebitda	Cost Of Revenue	Total Operating Expenses	Income Before Tax	Total Other Income Expense Net	Net Income	Income Tax Expense	Interest Expense	Selling General Administrative	Selling And Marketing Expenses	Tax Provision	Interest Income	Net Income From Continuing Ops	Net Interest Income	Reconciled Depreciation
Depreciation And Amortization		0.66	0.58	0.77	-0.84	-0.82	0.59	-0.62	0.81	0.72	-0.8	-0.2	-0.79	0.25	0.41	0.65	0.86	-0.21	-0.57	-0.84	-0.46	0.95
Total Revenue	0.66		0.99	0.96	-0.53	-0.6	0.92	-0.56	0.88	0.91	-0.71	-0.69	-0.71	0.22	0.93	0.75	0.84	-0.02	-0.63	-0.83	-0.91	0.71
Gross Profit	0.58	0.99		0.94	-0.47	-0.54	0.92	-0.53	0.8	0.9	-0.66	-0.72	-0.66	0.15	0.96	0.75	0.8	0.02	-0.6	-0.79	-0.93	0.64
Other Operating Expenses	0.77	0.96	0.94		-0.7	-0.75	0.94	-0.7	0.88	0.98	-0.81	-0.61	-0.81	0.16	0.88	0.84	0.85	-0.02	-0.57	-0.9	-0.9	0.83
Operating Income	-0.84	-0.53	-0.47	-0.7		0.99	-0.68	0.93	-0.66	-0.67	0.94	0.3	0.94	-0.01	-0.37	-0.7	-0.7	-0.05	0.44	0.89	0.46	-0.85
Ebit	-0.82	-0.6	-0.54	-0.75	0.99		-0.75	0.95	-0.68	-0.73	0.96	0.38	0.96	0.01	-0.46	-0.75	-0.72	-0.09	0.46	0.92	0.55	-0.85
Research Development	0.59	0.92	0.92	0.94	-0.68	-0.75		-0.8	0.76	0.91	-0.83	-0.75	-0.84	0.01	0.91	0.83	0.74	0.21	-0.54	-0.89	-0.92	0.69
Ebitda	-0.62	-0.56	-0.53	-0.7	0.93	0.95	-0.8		-0.57	-0.7	0.93	0.47	0.93	0.13	-0.51	-0.75	-0.59	-0.23	0.37	0.86	0.59	-0.7
Cost Of Revenue	0.81	0.88	0.8	0.88	-0.66	-0.68	0.76	-0.57		0.78	-0.76	-0.5	-0.76	0.38	0.7	0.61	0.85	-0.14	-0.65	-0.83	-0.69	0.82
Total Operating Expenses	0.72	0.91	0.9	0.98	-0.67	-0.73	0.91	-0.7	0.78		-0.77	-0.55	-0.77	0.09	0.87	0.86	0.78	-0.01	-0.46	-0.84	-0.9	0.8
Income Before Tax	-0.8	-0.71	-0.66	-0.81	0.94	0.96	-0.83	0.93	-0.76	-0.77		0.59	1.0	-0.04	-0.59	-0.81	-0.77	-0.11	0.5	0.95	0.66	-0.82
Total Other Income Expense Net	-0.2	-0.69	-0.72	-0.61	0.3	0.38	-0.75	0.47	-0.5	-0.55	0.59		0.6	0.12	-0.76	-0.59	-0.46	-0.2	0.39	0.56	0.76	-0.25
Net Income	-0.79	-0.71	-0.66	-0.81	0.94	0.96	-0.84	0.93	-0.76	-0.77	1.0	0.6		-0.05	-0.6	-0.81	-0.77	-0.13	0.5	0.95	0.67	-0.82
Income Tax Expense	0.25	0.22	0.15	0.16	-0.01	0.01	0.01	0.13	0.38	0.09	-0.04	0.12	-0.05		0.15	0.01	0.24	0.14	0.03	-0.11	-0.07	0.22
Interest Expense	0.41	0.93	0.96	0.88	-0.37	-0.46	0.91	-0.51	0.7	0.87	-0.59	-0.76	-0.6	0.15		0.73	0.64	0.21	-0.42	-0.69	-0.97	0.51
Selling General Administrative	0.65	0.75	0.75	0.84	-0.7	-0.75	0.83	-0.75	0.61	0.86	-0.81	-0.59	-0.81	0.01	0.73		0.75	0.14	-0.39	-0.82	-0.82	0.65
Selling And Marketing Expenses	0.86	0.84	0.8	0.85	-0.7	-0.72	0.74	-0.59	0.85	0.78	-0.77	-0.46	-0.77	0.24	0.64	0.75		-0.23	-0.7	-0.89	-0.67	0.78
Tax Provision	-0.21	-0.02	0.02	-0.02	-0.05	-0.09	0.21	-0.23	-0.14	-0.01	-0.11	-0.2	-0.13	0.14	0.21	0.14	-0.23		0.24	-0.04	-0.19	-0.11
Interest Income	-0.57	-0.63	-0.6	-0.57	0.44	0.46	-0.54	0.37	-0.65	-0.46	0.5	0.39	0.5	0.03	-0.42	-0.39	-0.7	0.24		0.66	0.41	-0.54
Net Income From Continuing Ops	-0.84	-0.83	-0.79	-0.9	0.89	0.92	-0.89	0.86	-0.83	-0.84	0.95	0.56	0.95	-0.11	-0.69	-0.82	-0.89	-0.04	0.66		0.74	-0.86
Net Interest Income	-0.46	-0.91	-0.93	-0.9	0.46	0.55	-0.92	0.59	-0.69	-0.9	0.66	0.76	0.67	-0.07	-0.97	-0.82	-0.67	-0.19	0.41	0.74		-0.53
Reconciled Depreciation	0.95	0.71	0.64	0.83	-0.85	-0.85	0.69	-0.7	0.82	0.8	-0.82	-0.25	-0.82	0.22	0.51	0.65	0.78	-0.11	-0.54	-0.86	-0.53

Click cells to compare fundamentals

Theratechnologies Account Relationship Matchups

Theratechnologies income statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Depreciation And Amortization	8.8M	8.6M	12.0M	3.3M	3.8M	3.1M
Total Revenue	66.1M	69.8M	80.1M	81.8M	94.0M	98.7M
Gross Profit	39.2M	46.6M	53.8M	62.1M	71.4M	75.0M
Other Operating Expenses	84.0M	95.1M	120.0M	92.4M	106.2M	111.6M
Operating Income	(18.0M)	(25.2M)	(39.9M)	(10.6M)	(9.6M)	(10.0M)
Ebit	(18.0M)	(25.7M)	(39.9M)	(13.6M)	(12.3M)	(12.9M)
Research Development	18.0M	28.3M	36.9M	30.4M	34.9M	36.7M
Ebitda	(9.2M)	(17.2M)	(27.9M)	(10.3M)	(11.9M)	(12.5M)
Cost Of Revenue	26.9M	23.3M	26.3M	19.6M	22.6M	23.7M
Total Operating Expenses	57.1M	71.8M	93.7M	72.8M	83.7M	87.9M
Income Before Tax	(22.7M)	(31.7M)	(46.8M)	(23.5M)	(21.2M)	(20.1M)
Total Other Income Expense Net	(4.7M)	(6.4M)	(6.9M)	(12.9M)	(11.6M)	(11.0M)
Net Income	(22.7M)	(31.7M)	(47.2M)	(24.0M)	(21.6M)	(20.5M)
Income Tax Expense	16K	63K	443K	421K	484.2K	508.4K
Interest Expense	5.4M	5.7M	6.5M	10.5M	12.1M	12.7M
Selling General Administrative	12.2M	14.6M	17.4M	15.6M	18.0M	9.3M
Selling And Marketing Expenses	26.9M	28.9M	39.4M	26.8M	30.8M	16.5M
Tax Provision	16K	63K	443K	421K	484.2K	508.4K
Interest Income	299K	195K	316K	769K	692.1K	457.6K
Net Income From Continuing Ops	(22.7M)	(31.7M)	(47.2M)	(24.0M)	(21.6M)	(22.6M)
Net Income Applicable To Common Shares	(12.5M)	(22.7M)	(31.7M)	(47.2M)	(42.5M)	(40.4M)
Net Interest Income	(5.1M)	(6.4M)	(6.2M)	(10.6M)	(9.5M)	(9.1M)
Reconciled Depreciation	8.5M	8.7M	12.5M	3.3M	3.8M	7.3M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

Additional Tools for Theratechnologies Stock Analysis

When running Theratechnologies' price analysis, check to measure Theratechnologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Theratechnologies is operating at the current time. Most of Theratechnologies' value examination focuses on studying past and present price action to predict the probability of Theratechnologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Theratechnologies' price. Additionally, you may evaluate how the addition of Theratechnologies to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Theratechnologies Historical Income Statement

About Theratechnologies Income Statement Analysis

Theratechnologies Income Statement Chart

Depreciation And Amortization

Total Revenue

Other Operating Expenses

Cost Of Revenue

Theratechnologies income statement Correlations

Theratechnologies Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Theratechnologies income statement Accounts

Also Currently Popular

Additional Tools for Theratechnologies Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Net Income	+ 1.0	Income Before Tax
Gross Profit	+ 0.99	Total Revenue
Ebit	+ 0.99	Operating Income
Total Operating Expenses	+ 0.98	Other Operating Expenses
Other Operating Expenses	+ 0.96	Total Revenue
Interest Expense	+ 0.96	Gross Profit

Net Interest Income	- 0.97	Interest Expense
Net Interest Income	- 0.93	Gross Profit
Net Interest Income	- 0.92	Research Development
Net Interest Income	- 0.91	Total Revenue
Net Interest Income	- 0.9	Total Operating Expenses
Net Interest Income	- 0.9	Other Operating Expenses